Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis

Weihua Ni, Kensuke Egashira, Chu Kataoka, Shiro Kitamoto, Masamichi Koyanagi, Shujiro Inoue, Akira Takeshita

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Recent studies suggest that some of the beneficial effects of 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) may be due to their cholesterol-lowering independent effects on the blood vessels. Chronic inhibition of endothelial nitric oxide (NO) synthesis by oral administration of Nw-nitro-L-arginine methyl ester (L-NAME) to rats induces early vascular inflammation as well as subsequent arteriosclerosis. The aim of the study is to test whether treatment with statins attenuates such arteriosclerotic changes through their cholesterol-lowering independent effects. We investigated the effect of statins (pravastatin and cerivastatin) on the arteriosclerotic changes in the rat model. We found that treatment with statins did not affect serum lipid levels but markedly inhibited the L-NAME-induced vascular inflammation and arteriosclerosis. Treatment with statins augmented endothelial NO synthase activity in L-NAME-treated rats. We also found the L-NAME induced increase in Rho membrane translocation in hearts and its prevention by statins. Such vasculoprotective effects of statins were suppressed by the higher dose of L-NAME. In summary, in this study, we found that statins such as pravastatin and cerivastatin inhibited vascular inflammation and arteriosclerosis through their lipid-lowering independent actions in this model. Such antiarteriosclerotic effects may involve the increase in endothelial NO synthase activity and the inhibition of Rho activity.

Original languageEnglish
Pages (from-to)415-421
Number of pages7
JournalCirculation research
Volume89
Issue number5
DOIs
Publication statusPublished - Aug 31 2001

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Coenzyme A
Hydroxyl Radical
Oxidoreductases
Nitric Oxide
Anti-Inflammatory Agents
NG-Nitroarginine Methyl Ester
Blood Vessels
Arteriosclerosis
Pravastatin
Nitric Oxide Synthase Type III
Inflammation
Cholesterol
Lipids
Oral Administration
Therapeutics
Membranes

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. / Ni, Weihua; Egashira, Kensuke; Kataoka, Chu; Kitamoto, Shiro; Koyanagi, Masamichi; Inoue, Shujiro; Takeshita, Akira.

In: Circulation research, Vol. 89, No. 5, 31.08.2001, p. 415-421.

Research output: Contribution to journalArticle

Ni, Weihua ; Egashira, Kensuke ; Kataoka, Chu ; Kitamoto, Shiro ; Koyanagi, Masamichi ; Inoue, Shujiro ; Takeshita, Akira. / Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. In: Circulation research. 2001 ; Vol. 89, No. 5. pp. 415-421.
@article{a0674719acc540fcb48f97212f588a8b,
title = "Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis",
abstract = "Recent studies suggest that some of the beneficial effects of 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) may be due to their cholesterol-lowering independent effects on the blood vessels. Chronic inhibition of endothelial nitric oxide (NO) synthesis by oral administration of Nw-nitro-L-arginine methyl ester (L-NAME) to rats induces early vascular inflammation as well as subsequent arteriosclerosis. The aim of the study is to test whether treatment with statins attenuates such arteriosclerotic changes through their cholesterol-lowering independent effects. We investigated the effect of statins (pravastatin and cerivastatin) on the arteriosclerotic changes in the rat model. We found that treatment with statins did not affect serum lipid levels but markedly inhibited the L-NAME-induced vascular inflammation and arteriosclerosis. Treatment with statins augmented endothelial NO synthase activity in L-NAME-treated rats. We also found the L-NAME induced increase in Rho membrane translocation in hearts and its prevention by statins. Such vasculoprotective effects of statins were suppressed by the higher dose of L-NAME. In summary, in this study, we found that statins such as pravastatin and cerivastatin inhibited vascular inflammation and arteriosclerosis through their lipid-lowering independent actions in this model. Such antiarteriosclerotic effects may involve the increase in endothelial NO synthase activity and the inhibition of Rho activity.",
author = "Weihua Ni and Kensuke Egashira and Chu Kataoka and Shiro Kitamoto and Masamichi Koyanagi and Shujiro Inoue and Akira Takeshita",
year = "2001",
month = "8",
day = "31",
doi = "10.1161/hh1701.096614",
language = "English",
volume = "89",
pages = "415--421",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis

AU - Ni, Weihua

AU - Egashira, Kensuke

AU - Kataoka, Chu

AU - Kitamoto, Shiro

AU - Koyanagi, Masamichi

AU - Inoue, Shujiro

AU - Takeshita, Akira

PY - 2001/8/31

Y1 - 2001/8/31

N2 - Recent studies suggest that some of the beneficial effects of 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) may be due to their cholesterol-lowering independent effects on the blood vessels. Chronic inhibition of endothelial nitric oxide (NO) synthesis by oral administration of Nw-nitro-L-arginine methyl ester (L-NAME) to rats induces early vascular inflammation as well as subsequent arteriosclerosis. The aim of the study is to test whether treatment with statins attenuates such arteriosclerotic changes through their cholesterol-lowering independent effects. We investigated the effect of statins (pravastatin and cerivastatin) on the arteriosclerotic changes in the rat model. We found that treatment with statins did not affect serum lipid levels but markedly inhibited the L-NAME-induced vascular inflammation and arteriosclerosis. Treatment with statins augmented endothelial NO synthase activity in L-NAME-treated rats. We also found the L-NAME induced increase in Rho membrane translocation in hearts and its prevention by statins. Such vasculoprotective effects of statins were suppressed by the higher dose of L-NAME. In summary, in this study, we found that statins such as pravastatin and cerivastatin inhibited vascular inflammation and arteriosclerosis through their lipid-lowering independent actions in this model. Such antiarteriosclerotic effects may involve the increase in endothelial NO synthase activity and the inhibition of Rho activity.

AB - Recent studies suggest that some of the beneficial effects of 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) may be due to their cholesterol-lowering independent effects on the blood vessels. Chronic inhibition of endothelial nitric oxide (NO) synthesis by oral administration of Nw-nitro-L-arginine methyl ester (L-NAME) to rats induces early vascular inflammation as well as subsequent arteriosclerosis. The aim of the study is to test whether treatment with statins attenuates such arteriosclerotic changes through their cholesterol-lowering independent effects. We investigated the effect of statins (pravastatin and cerivastatin) on the arteriosclerotic changes in the rat model. We found that treatment with statins did not affect serum lipid levels but markedly inhibited the L-NAME-induced vascular inflammation and arteriosclerosis. Treatment with statins augmented endothelial NO synthase activity in L-NAME-treated rats. We also found the L-NAME induced increase in Rho membrane translocation in hearts and its prevention by statins. Such vasculoprotective effects of statins were suppressed by the higher dose of L-NAME. In summary, in this study, we found that statins such as pravastatin and cerivastatin inhibited vascular inflammation and arteriosclerosis through their lipid-lowering independent actions in this model. Such antiarteriosclerotic effects may involve the increase in endothelial NO synthase activity and the inhibition of Rho activity.

UR - http://www.scopus.com/inward/record.url?scp=0035980169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035980169&partnerID=8YFLogxK

U2 - 10.1161/hh1701.096614

DO - 10.1161/hh1701.096614

M3 - Article

C2 - 11532902

AN - SCOPUS:0035980169

VL - 89

SP - 415

EP - 421

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -